Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



WORLAND STEPHEN T Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 4 WORLAND STEPHEN T (CEO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Exercised 33,799 options to buy @ $0.52, valued at $17.6k
05/16/2023 4 WORLAND STEPHEN T (CEO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 6,401 shares @ $0.459, valued at $2.9k
04/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/19/2023 4 WORLAND STEPHEN T (CEO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 1,000,000 options to buy @ $0.47, valued at $470k
11/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/24/2022 4 WORLAND STEPHEN T (President and Chief Executive) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 520,674 options to buy @ $6.65, valued at $3.5M
08/27/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/27/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
06/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2020 4 WORLAND STEPHEN T (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.
Txns: Granted 4,500 options to buy @ $2.07, valued at $9.3k
06/17/2019 4 WORLAND STEPHEN T (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $0.635, valued at $9.5k
06/13/2018 4 WORLAND STEPHEN T (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $2.7, valued at $40.5k
06/15/2017 4 WORLAND STEPHEN T (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $2.15, valued at $32.3k
06/02/2016 4 WORLAND STEPHEN T (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.
Txns: Granted 7,500 shares @ $0
07/24/2015 4 WORLAND STEPHEN T (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $13.02, valued at $195.3k
Granted 6,103 options to buy @ $13.02, valued at $79.5k
02/27/2015 4 WORLAND STEPHEN T (Director) has filed a Form 4 on Tracon Pharmaceuticals, Inc.
Txns: Granted 18,897 options to buy @ $13.4, valued at $253.2k
06/02/2014 4 WORLAND STEPHEN T (Director) has filed a Form 4 on GenMark Diagnostics, Inc.
Txns: Granted 5,677 shares @ $0
05/23/2013 4 WORLAND STEPHEN T (Director) has filed a Form 4 on GenMark Diagnostics, Inc.
Txns: Granted 14,922 shares @ $0
06/15/2012 4 WORLAND STEPHEN T (Director) has filed a Form 4 on GenMark Diagnostics, Inc.
Txns: Granted 25,000 options to buy @ $4.34, valued at $108.5k
06/15/2012 3 WORLAND STEPHEN T (Director) has filed a Form 3 on GenMark Diagnostics, Inc.
12/15/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
12/07/2009 4 Form 4 - Statement of changes in beneficial ownership of securities
08/20/2009 4 WORLAND STEPHEN T (President and CEO) has filed a Form 4 on ANADYS PHARMACEUTICALS INC
12/12/2008 4 WORLAND STEPHEN T (President and CEO) has filed a Form 4 on ANADYS PHARMACEUTICALS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy